Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder - A study with magnetic resonance spectroscopy

Biological Psychiatry

Volumn 41, Issue 8, 1997, Pages 844-850

  Riedl, Ulrich ^a   Barocka, Arnd ^a   Kolem, Heinrich ^b   Demling, Joachim ^a   Kaschka, Wolfgang P ^c   Schelp, Rainer ^a   Stemmler, Mark ^a   Ebert, Dieter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b SIEMENS AG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Lithium; Magnetic resonance spectroscopy; Schizoaffective disorder; Unipolar disorder

Indexed keywords

LITHIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG BRAIN LEVEL; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SPECTROSCOPY;

ADULT; ANTIMANIC AGENTS; BRAIN; CALIBRATION; DEPRESSIVE DISORDER; FEMALE; HUMANS; LITHIUM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RADIOISOTOPES; TIME FACTORS;

EID: 0030938407     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00330-7     Document Type: Article

References (12)

1. González G (1993): Measurement of human brain lithium in vivo by MR-spectroscopy. Am J Neurorad 14:1027-1037.
2. Gyulai L, Wicklund SW, Greenstein R, et al (1991): Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biol Psychiatry 29:1161-1170.
3. Heurteaux C, Baumann N, Lachapelle F, Wissocq JC, Thellier M (1986): Lithium distribution in the brain of normal mice and of "quaking" dysmyelinating mutants. J Neurochem 46: 1317-1321.
4. Kato T, Takahashi S, Inubushi T (1992): Brain lithium concentration by 7-Li-and 1-H-magnetic resonance spectroscopy in bipolar disorder. Psychiatry Res Neuroimaging 45:53-63.
5. Kato T, Shioiri T, Inubushi T, Takahashi S (1993a): Brain lithium concentrations measured with lithium magnetic resonance spectroscopy in patients with affective disorders: Relationship to erythrocyte and serum concentrations. Biol Psychiatry 33:147-152.
6. Kato T, Takahashi S, Shioiri T, Inubushi T (1993b): Alterations in brain phosphorus metabolism in bipolar disorder detected by in vivo 31-P-and 7-Li-magnetic resonance spectroscopy. J Affect Disord 27:53-60.
7. Kato T, Inubushi T, Takahashi S (1994): Relationship of lithium concentrations in the brain measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. J Clin Psychopharmacol 14:330-335.
8. Komoroski RA, Newton JEO, Walker E, et al (1990): In vivo NMR spectroscopy of lithium-7 in humans. Magn Reson Med 15:347-356.
9. Komoroski RA, Newton JEO, Sprigg JR, Cardwell D, Mohanakrishnan P, Karson CN (1993): In vivo 7-Li-nuclear magnetic resonance study of lithium pharmacokinetics and chemical shift imaging in psychiatric patients. Psychiatry Res Neuroimaging 50:67-76.
10. Kushnir T, Itzchak Y, Valevski A, Lask M, Modai I, Navon G (1993): Relaxation times and concentrations of 7-Li in the brain of patients receiving lithium therapy. NMR Biomed 6:39-42.
11. Renshaw PF, Wicklund S (1988): In vivo measurement of lithium in humans by nuclear magnetic resonance spectroscopy. Biol Psychiatry 23:465-475.
12. Schou M (1983): Lithium Treatment of Manic-Depressive Illness: A Practical Guide, 2nd ed rev. Basle: Karger.